Hanna Kunina
PhD student at Department of Pharmacy; Pharmacometrics
- E-mail:
- hanna.kunina@uu.se
- Visiting address:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postal address:
- Box 580
751 23 UPPSALA
Download contact information for Hanna Kunina at Department of Pharmacy; Pharmacometrics

Publications
Recent publications
-
Pharmacometric Modeling of Disease Progression and Biomarker Dynamics in Type 2 Diabetes
2026
-
Part of AAPS Journal, 2026
- DOI for Blood-glucose Profile Evaluation with a Model-based Approach using Continuous Glucose Monitoring Data
- Download full text (pdf) of Blood-glucose Profile Evaluation with a Model-based Approach using Continuous Glucose Monitoring Data
-
Part of CPT, p. 606-615, 2025
- DOI for Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality
- Download full text (pdf) of Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality
-
Part of CPT, p. 1443-1457, 2022
- DOI for Optimization of trial duration to predict long-term HbA1c change with therapy: A pharmacometrics simulation-based evaluation
- Download full text (pdf) of Optimization of trial duration to predict long-term HbA1c change with therapy: A pharmacometrics simulation-based evaluation
All publications
Articles in journal
-
Part of AAPS Journal, 2026
- DOI for Blood-glucose Profile Evaluation with a Model-based Approach using Continuous Glucose Monitoring Data
- Download full text (pdf) of Blood-glucose Profile Evaluation with a Model-based Approach using Continuous Glucose Monitoring Data
-
Part of CPT, p. 606-615, 2025
- DOI for Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality
- Download full text (pdf) of Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality
-
Part of CPT, p. 1443-1457, 2022
- DOI for Optimization of trial duration to predict long-term HbA1c change with therapy: A pharmacometrics simulation-based evaluation
- Download full text (pdf) of Optimization of trial duration to predict long-term HbA1c change with therapy: A pharmacometrics simulation-based evaluation